Human SNF5 (hSNF5; INI1, SMARCB1 or BAF47) is a component of the human SWI/SNF chromatin remodelling complex and a tumour suppressor mutated in rhabdoid tumours. It also associates with the integrase of the human immunodeficiency virus (HIV)-1. We show by fluorescence loss in photobleaching that hSNF5 is constantly shuttling between the nucleus and the cytoplasm, raising the question of what the role of hSNF5 is in the cytoplasm. Here, we demonstrate that hSNF5 directly interacts with the GTPase dynamin-2 (DNM2) in the cytoplasm. DNM2 is a large GTPase involved in endocytosis and vesicle dynamics, which has been related to HIV-1 internalization. We show that hSNF5 colocalizes with DNM2 in endocytic vesicles. Depletion of hSNF5, but not of other components of the SWI/SNF complex, destabilizes DNM2 and impairs DNM2-dependent endocytosis. Furthermore, we show that hSNF5 inhibits assembly-stimulated DNM2 GTPase activity but not basal GTPase activity in vitro. Altogether, these results indicate that hSNF5 affects both the stability and the activity of DNM2, uncovering an unexpected role of hSNF5 in modulating endocytosis, and open new perspectives in understanding the role of hSNF5 in tumour genesis.
INTRODUCTION
The SWI/SNF complex is an evolutionarily conserved multisubunit chromatin remodelling complex that uses ATP to destabilize interactions between histones and DNA. 1 This complex has an essential role in transcription, and mutations in genes encoding SWI/SNF components have been linked to several types of cancer and congenital malformations. Human SNF5 (hSNF5, also known as INI1, SMARCB1 or BAF47) is one of the subunits of the human SWI/SNF complex. Either germ line or somatic mutations at the hSNF5 gene predispose to malignant rhabdoid tumours (MRTs), an aggressive type of paediatric cancer that develops from loss of heterozygosity after bi-allelic inactivation. 2 In addition to MRTs, bi-allelic mutations of hSNF5 occur in familial schwannomatosis and occasionally in other cancers (reviewed in Roberts et al. 3 and Wilson et al. 4 ). All these data indicate that hSNF5 is a tumour suppressor gene. This fact has been confirmed in the mouse models, as snf5 heterozygous mice develop tumours that resemble human MRT. [5] [6] [7] Mutations in other SWI/SNF subunit genes have been recently identified in several types of tumours, although they differ from MRTs (reviewed in Wilson et al. 4 ). These differences suggest that hSNF5 has specific roles inside the SWI/SNF complex or that it accounts for additional roles outside. The function of hSNF5 in the complex is unclear, although interaction of hSNF5 with many transcription factors suggests a role in recruiting the complex to target genes (reviewed in Stojanova and Penn 8 ) . hSNF5 also associates with the human immunodeficiency virus (HIV)-1 integrase, being selectively incorporated into HIV-1 virions. 9 Turelli et al. 10 reported that hSNF5 exits the nucleus upon HIV-1 infection. This nucleocytoplasmic transport is exportin mediated and transient, as nuclear localization is recovered a few hours after inoculation. Later, Craig et al. 11 showed that hSNF5 presents a masked nuclear export signal (NES), the role of which remains unknown.
In this work, we demonstrate that hSNF5 constantly shuttles between nucleus and cytoplasm, which prompted us to investigate hSNF5 cytoplasmic partners, identifying the large GTPase dynamin-2 (DNM2). DNM2 is a mechanochemical enzyme required for vesicle fission in different processes such as endocytosis of clathrin-coated pits, budding of caveoli, phagocytosis and endosome vesicles traffic. 12 We show that downregulating hSNF5, but not other members of the SWI/SNF complex, decreases DNM2-dependent endocytosis. Furthermore, we demonstrate that hSNF5 impairs DNM2 GTPase activity in vitro but does not inhibit DNM2 self-assembly. Finally, we also show that hSNF5 depleted cells display decreased levels of DNM2. Therefore, our data show an unexpected role of hSNF5 in regulating endocytosis.
RESULTS
hSNF5 shuttles between nucleus and cytoplasm It has been shown that hSNF5 has a NES and is transiently exported from the nucleus to the cytoplasm upon HIV-1 infection. 10, 11 As this NES is evolutionary conserved, we hypothesized that it should also be relevant under normal growth conditions. Biochemical fractionation evidenced the presence of hSNF5 at both the nuclear and the cytoplasmic compartments in different cell lines (Figure 1a ). In contrast, other subunits of the human SWI/SNF complex (BRG1, hBRM and BAF180) were only found in the nuclear fraction ( Figure 1a ).
In order to verify this finding, we analysed the distribution of GFP-or YFP-tagged BRG1, hBRM and hSNF5 in transfected cells. Whereas YFP-BRG1 and GFP-hBRM exclusively localized to the nucleus, GFP-hSNF5 appeared both in the nucleus and in the cytoplasm (Figure 1b) , irrespective of the amount of DNA used in the transfection or the degree of expression of the fusion protein (Supplementary Figure S1) . On the basis of western blotting signal intensities and transfection efficiency, we estimate that the amount of expressed GFP-hSNF5 in HeLa cells was about twofold higher than that of the endogenous hSNF5 protein, confirming that GFP-hSNF5 is expressed at physiological-like levels (Supplementary Figure S2) . Furthermore, two different antibodies against endogenous hSNF5 showed a significant cytoplasmic signal besides nuclear staining (Figure 1c) . Thus, our data indicate that a fraction of the hSNF5 pool is present in the cytoplasm.
To analyse whether hSNF5 shuttles between the nucleus and the cytoplasm in vivo, fluorescence loss in photobleaching analysis was performed. 13 Thus, a small region of the cytoplasm was bleached for consecutive periods of 33 s with maximum laser intensity, and the fluorescence of the nucleus was recorded. To discard generalized bleaching, we monitored an unbleached neighbouring cell in which the fluorescence remained unaltered (Figure 2a) . Behaviour of GFP-hSNF5 was compared with that of GFP alone or GFP-histone H2A. The nuclear and cytoplasmic fluorescence of GFP-expressing cells was lost after 800 s, consistent with free diffusion of GFP in the cell. However, no loss of fluorescence was detected in the nucleus of GFP-histone H2A-expressing cells after 800 s of bleaching, indicating that GFP-histone H2A is restricted to the nucleus (Figure 2a and quantification in Figure 2b ). In clear contrast, nuclear fluorescence of GFP-hSNF5 decreased to about 25% of the original signal after 800 s of cytoplasmic bleaching (Figures 2a and b) , indicating that most of the GFP-hSNF5 molecules passed through the cytoplasmic region bleached and suggesting that hSNF5 is constantly shuttling between the nucleus and the cytoplasm. Deletion of the hSNF5 NES (amino acids 263-275, GFP-DNES) significantly reduced the loss of nuclear fluorescence (Figure 2b ), demonstrating the functionality of this sequence in hSNF5 shuttling.
hSNF5 interacts with DNM2 in endocytic vesicles We decided to look for cytoplasmic partners of hSNF5 that would help us understand the functions of this tumour suppressor outside the nucleus. Consequently, an yeast two-hybrid screening of an 8.5-d.p.c. mouse embryo cDNA library was performed, using full-length hSNF5 as the bait. A total of 11 out of 2 Â 10 6 transformants were isolated in selective medium and their respective cDNAs were subjected to nucleotide sequence analysis ( Table 1) . Three of the clones corresponded to SMARCC2 (also known as BAF170), a subunit of the SWI/SNF complex. This result validates our screening, as yeast and Drosophila homologues of SMARCC2 are known to directly interact with its SNF5 counterparts. 14, 15 Other putative identified interactors of hSNF5 were the transcription factors IKAROS, HOXA11 and HOXA10, the Polycomb factor SCMH1, the translation elongation factor EIF2B2, the component of the oligomeric Golgi complex COG-2 and the large GTPase DNM2 (Table 1) . As yeast clones expressing DNM2 displayed a robust growth on selective medium (data not shown) and DNM2 is a cytoplasmic protein with multiple and well-known functions in membrane and cytoskeleton dynamics and signalling, 12 we decided to investigate the consequences of hSNF5-DNM2 interaction. Yeast two-hybrid mapping of the interacting domains revealed that the carboxy-terminal HR3 domain of hSNF5 was necessary but not sufficient for interaction (Figure 3a) , as the amino terminal half of the protein (Nter) also contributed to the interaction. Thus, cells expressing a fusion of Nter with the HR3 domain displayed a robust growth similar to cells expressing the full-length hSNF5 protein (Figure 3a) . Deletion analysis of DNM2 Figure 3a) . Consistently, recent studies demonstrate that part of the GTPase and GED domains fold together in a structural element called the bundle signalling element. 16, 17 Dynamins act as classical regulatory GTPases that change conformation depending on the presence of GTP or GDP in the GTPase domain. To investigate whether GTP biding affected hSNF5-DNM2 interaction, we performed in vitro pull-down experiments with glutathione S-transferase (GST) or a GST-hSNF5 fusion and histidine-tagged DNM2 (His-DNM2) in the presence of GTPgS (a non-hydrolysable GTP analogue) or GDP. Figure 3b shows that hSNF5 was able to interact in vitro with DNM2 regardless of the added molecule. Furthermore, interaction in different conditions was confirmed by co-immunoprecipitation (Figure 3c ). To investigate the interaction of endogenous hSNF5 and DNM2 proteins, we used an in situ proximity ligation assay (PLA). This assay allows detection of protein-protein association and subcellular localization of the interaction by using two different primary antibodies and two specific secondary antibodies bound to short unique DNA strands (PLA probes). If the PLA probes are in close proximity (o40 nm), the DNA strands can interact; DNA can be amplified, fluorescencelabelled and detected. When PLA was performed with anti-hSNF5 or anti-DNM2 and both PLA secondary antibodies very few dots were detected. However, when anti-hSNF5 and anti-DNM2 were used together, a strong, mostly cytoplasmic, PLA signal was detected, indicating the association between the proteins (Figure 4a and quantification in Figure 4b ). Figure 4c shows immunolocalization of endogenous hSNF5 and DNM2 in HeLa cells using the primary antibodies utilized in the PLA. Control experiments using antibodies against hSNF5 and BAF155 (positive control) or against hSNF5 and carbamoyl-phosphate synthetase 2, aspartate transcarbamylase and dihydroorotase (CAD; negative control) confirmed the specificity of the hSNF5-DNM2 association visualized using the in situ PLA (Supplementary Figures S3a-c) .
DNM2 has an important role in endocytosis of clathrinmediated pits, where it is believed to directly provoke membrane fission and vesicle release.
12 Transferrin (tfn) is internalized by clathrin-dependent endocytosis. 18 To determine whether hSNF5 and DNM2 colocalized in endocytic vesicles, COS-7 cells expressing haemagglutinin (Ha)-DNM2 and GFP-hSNF5 were treated with labelled tfn (tranferrin Alexa-Fluor-647 conjugated). Western blot experiments demonstrated that, in COS-7 cells, Ha-tagged DNM2 (Ha-DNM2) and GFP-hSNF5 were overexpressed about two-and fivefold, respectively (Supplementary Figure S2) . Fluorescence intensity profiles along lines drawn in the cytoplasmic area show that GFP-hSNF5, Ha-DNM2 and tnf stains often colocalize in a punctuated structure (Figures 4d-f ). About 66% of the Ha-DNM2-positive dots also contained GFP-hSNF5 and approximately 81% of the GFP-hSNF5-positive dots also contained Ha-DNM2. About 20% of the tnf-positive vesicles also contained Ha-DNM2 (Figure 4f ), consistently with the fact that DNM2 is not hSNF5-DNM2 interaction T Alfonso-Pé rez et al continuously associated with endocytic vesicles. 19 Interestingly, about 48% of the tnf-positive vesicles that contained Ha-DNM2 also contained GFP-hSNF5. However, a small amount of tnf vesicles (1.9%) contained GFP-hSNF5 but no detectable levels of Ha-DNM2, suggesting that DNM2 recruits hSNF5 to the vesicles ( Figure 4f ). Taken together, these data indicate that hSNF5 interacts with DNM2 in cytoplasmic endocytic vesicles.
hSNF5 participates in DNM2-dependent endocytosis In order to investigate the functional consequences of the hSNF5-DNM2 interaction, we performed hSNF5 loss-of-function experiments and analysed typical DNM2-dependent functions. Clathrin-dependent endocytosis was evaluated by measuring tfn internalization in HeLa cells. We analysed whether tfn uptake is affected upon silencing of endogenous hSNF5 by RNA interference. As a control, we first verified that knockdown of DNM2 strongly impaired tfn uptake ( Figure 5a and quantification in Figure 5c ). Interestingly, hSNF5 knockdown also provoked a strong decrease of tfn internalization (Figures 5a and c), suggesting that hSNF5 is involved in endocytosis. Similar results were obtained in RPE1 cells (Supplementary Figure S4) or using a small hairpin RNA that targets a different region of hSNF5 (Supplementary Figure S5) . Knockdown of hBRM, BRG1 or both, which code for the mutually exclusive essential ATPases of the SWI/SNF complex, did not affect endocytosis, indicating that the effect of hSNF5 on endocytosis is not related to the SWI/SNF complex (Figures 5b and c) . In order to investigate whether other endocytic pathways were affected by hSNF5, we assayed fluid-phase endocytosis by measuring internalization of labelled dextran (dxt). It has been reported that DNM2 is involved in basal (non-stimulated) fluid-phase endocytosis, being the effect of DNM2 depletion much less evident when cells are epidermal growth factor (EGF)-stimulated, and most of fluid-phase endocytosis occurs by macropinocitosis. 20 We have monitored dxt internalization in HeLa cells stimulated or not with EGF. Depletion of DNM2 led to a 46% reduction in dxt internalization, whereas the depletion resulted in only 16% reduction under EGF stimulation (Figure 6a and quantification in Figure 6b ), consistent with previous reports. 20 Similarly, knockdown of hSNF5 also provoked a 40% reduction under nonstimulated conditions and had no effect in the presence of EGF, indicating that hSNF5 silencing does not affect all endocytic processes but those that are DNM2-dependent.
hSNF5 inhibits the GTPase activity of DNM2 In order to explore the mechanism by which hSNF5 has an effect on DNM2-depenent endocytosis, we tested whether hSNF5 has an effect on the GTPase activity of DNM2 in vitro, using the affinitypurified fusion proteins GST-hSNF5 and His-DNM2. Basal GTPase activity was assayed under high salt concentration conditions in which most DNM2 is forming dimers 21 or tetramers. 22, 23 Under these conditions, GST-hSNF5 had no effect on the activity of His-DNM2 (Figure 7a ). Under low ionic strength conditions DNM2 selfassembles into sedimentable structures composed of rings and small stacks. 22 It is well known that DNM2 self-assembly stimulates its GTPase activity. 24 Importantly, when GTPase activity was assayed under conditions of low ionic strength, GST-hSNF5 significantly inhibited His-DNM2 activity ( Figure 7b) . As a control, we verified that identical concentrations of GST alone had no Figure 7c ). Increasing amounts of GST-hSNF5 did not further decrease the GTPase activity (Figure 7c ), but it was noticed that part of the His-DNM2 protein appeared in the supernatant fraction ( Figure 7b inset; see Discussion). Then, we tested whether hSNF5 impairs DNM2 self-assembly. To accomplish that, a sedimentation assay was performed in which assembly of DNM2 upon dilution into a low ionic strength buffer is measured by the fraction of DNM2 present in the supernatant and the pellet after sample centrifugation. As shown in Figure 7d , GST-hSNF5 did not affect DNM2 self-assembly. It has been published that hSNF5 is also able to form oligomers. 25 In the absence of DNM2, o50% of the total amount of GST-hSNF5 was found in the pellet after centrifugation. However, in the presence of His-DNM2, 495% of GST-hSNF5 was found in the pellet. As a control, we verified that the GST protein was mostly soluble both in the absence and in the presence of DNM2 (Figure 7d) . These experiments might suggest that hSNF5 co-precipitate with self-assembled DNM2. However, the co-precipitation could also reflect nonspecific aggregation, and therefore these data are not a demonstration of an interaction. Altogether, our data indicate that hSNF5 inhibits GTPase activity of self-assembled DNM2 without impairing DNM2 self-assembly.
Depletion of hSNF5 affects stability of DNM2 Finally, we investigate whether hSNF5 or other SWI/SNF components control the level of expression of DNM2. Figure 8a shows that depletion of hSNF5 did not affect DNM2 mRNA levels, ruling out a transcriptional role of hSNF5 on DNM2 expression. However, knockdown of hSNF5 provoked a decrease in DNM2 protein levels (Figure 8b ), suggesting that hSNF5 contributes to DNM2 stability. As a control, we verified that silencing of BRG1 or hBRM did not alter DNM2 levels (Figure 8c ), ruling out an involvement of the SWI/SNF complex in DMN2 stability. Taken together, these data suggest that the hSNF5-DNM2 interaction contribute to the stabilization of DNM2. reported that hSNF5 transiently exited the nucleus upon HIV-1 infection of CD4 þ HeLa cells, but the signal triggering this cytoplasmic recruitment remains unknown. Later, Kalpana and colleagues showed that truncated forms of hSNF5 lacking the carboxy-terminal HR3 domain displays a cytoplasmic localization, whereas the full-length protein appears in the nucleus. 11 They hypothesized that under normal conditions the carboxy-terminal part of hSNF5 hinders a NES sequence, and that interaction of the carboxy terminus with a signalling protein may unmask the NES and triggers nuclear export. However, function and regulation of this trafficking was not studied. Now, we show by biochemical fractionation and microscopy techniques that hSNF5 constantly shuttles between the nucleus and the cytoplasm, and that a fraction of the cellular hSNF5 pool remains in the cytoplasm, where it interacts with the large GTPase DNM2. Interestingly, the carboxy-terminal HR3 domain of hSNF5 is involved in the interaction. As DNM2 is mostly cytoplasmic, it seems unlikely that it unmasks the hSNF5 NES in the nucleus, but we cannot rule out that a small fraction of DNM2 enters the nucleus to trigger hSNF5 export. More importantly, we show that depletion of hSNF5 impairs DNM2-dependent endocytosis. How the nucleocytoplasmic traffic of hSNF5 is related to this role remains unknown. One possibility is that under certain conditions migration of hSNF5 to the cytoplasm is altered, which in turn would modulate endocytotic activity. Besides this, we cannot exclude additional functions associated with hSNF5 trafficking, for instance functions related to the SWI/SNF complex.
We have shown that hSNF5 interacts with DNM2 in both conformations of its catalytic cycle: in the presence of GDP or in the presence of a non-hydrolysable form of GTP. Depletion of hSNF5 affects both clathrin-dependent endocytosis and a component of the fluid-phase endocytosis, which are DNM2-dependent, but not EGF-stimulated fluid-phase endocytosis that is largely independent of DNM2, 20 demonstrating that hSNF5 only affects DNM2-dependent endocytosis. We have also shown that depletion of the SWI/SNF complex ATPases does not affect endocytosis, ruling out the possibility of a transcriptional effect through the SWI/SNF complex. How does hSNF5 affect DNM2 Figure 6 . hSNF5 knockdown affects non-EGF-stimulated fluid-phase endocytosis. (a) Downregulation of hSNF5 (green, left panels) or DNM2 (green, right panels) by siRNA molecules (sihSNF5, siDNM2) markedly reduces fluid-phase endocytosis in the absence of EGF ( À EGF, top panels), whereas no significant effects were observed under EGF stimulation conditions ( þ EGF, lower panels). The fluid-phase endocytosis was analysed by tetramethylrhodamine-dxt internalization (red) in HeLa cells. DNA was stained with 4' ,6-diamidino-2-phenylindole (DAPI; blue). Bars, 25 mm. (b) Quantification of dxt internalization from a. Dxt uptake was measured in confocal images by determining the integrated intensity per unit area using the MetaMorph software. Data are average ± s.d. of 4120 siRNA-silenced cells from 18 different fields from three independent experiments. In the case of control siRNA, all cells from 18 different fields were recorded. Statistical significance was analysed by the Student's t-test: *Po0.005.
hSNF5-DNM2 interaction T Alfonso-Pé rez et al activity? It has been proposed that DNM2 works in two steps. 26, 27 In the first step, DNM2 behaves as a regulatory GTPase, which in a GTP-bound form regulates clathrin coat rearrangement and drives constriction. Then, in the second step, assembly-stimulated GTP hydrolysis acts as a switch off mechanism for DNM2 that releases the vesicle. A precise equilibrium between the two steps is required. For example, DNM2 GED mutants with a reduced assembly-stimulated GTPase activity display an increased endocytosis of tfn in vivo. 26, 27 We have shown that hSNF5 is an inhibitor in vitro of the DNM2 assembly-stimulated GTPase activity, suggesting that hSNF5 contributes to maintain DNM2 in its GTP-bound active configuration. Despite the high level of DNM2 inhibition displayed by hSNF5, hSNF5 was not able to completely abolish assembly-stimulated GTPase activity (Figure 7c ), suggesting that binding of hSNF5 modulates but does not completely inhibit GTPase activity of self-assembled DNM2. However, it is also possible that non-inhibited activity corresponds to the nonassembled fraction of DNM2 present in the assay (Figure 7b inset) , which is not affected by hSNF5. A number of DNM2 interactors such as SNX9, BIN1/amphiphysin-2 and auxilin have been shown to modulate GTPase activity by altering its self-assembly activity. [28] [29] [30] In contrast, hSNF5 inhibits GTPase activity without affecting DNM2 oligomerization (Figure 7d) . Notably, our data also suggest that interaction with hSNF5 stabilizes DNM2 (Figure 8 ), although we cannot rule out that DNM2 instability in the absence of hSNF5 is an indirect effect provoked by the inhibition of endocytosis. BIN1/amphiphysin-2 also interacts with DNM2 and has a role in endocytic reclycing. 31, 32 Interestingly, it has recently been reported that the BIN1/amphiphysin-2 gene is downregulated in MRTs. 33 This might suggest that BIN1/amphiphysin-2 represents an additional mechanism controlling endocytosis dependent on hSNF5. However, we have not observed downregulation of BIN1/amphiphysin-2 gene after knocking down hSNF5 in HeLa cells (data not shown). Thus, whether BIN1/amphiphysin-2 downregulation is directly linked to hSNF5 depletion in MRTs or is just the consequence of an altered endocytosis, needs to be clarified.
Most MRTs originated by bi-allelic inactivation of hSNF5 contain a variable number of classic rhabdoid cells with large nuclei containing a single prominent nucleolus, and cytoplasm with distinct pale eosinophilic inclusions. 3 It is well documented that the SWI/SNF complex has a central role in tumour suppression, as somatic inactivating mutations in several subunits (such as BAF180, ARID1A, ARID1B and BRG1) have recently been identified at a high frequency in variety of cancers. 4 However, none of them display rhabdoid characteristics, raising the question of why inactivation of hSNF5 provokes different type of tumours. In this manuscript we describe a new function of hSNF5 that may be involved in its tumour-suppressing activity. The role of endocytosis in cancer is complex, with ambiguous functions either as tumour suppressor or as oncogenic pathway. 34 Endocytosis allows the internalization of signalling receptors and The analysis of the supernatants (S) and pellets (P) was performed by SDS-PAGE and visualized by Coomassie staining. The reactions were performed in low ionic strength buffer containing 2 mM of His-DNM2 (1); 2 mM of His-DNM2 and 0.5 (2) or 2 mM of GST (4); 2 mM of His-DNM2 and 0.5 (3) or 2 mM of GST-hSNF5 (5); 0.5 (6) or 2 mM of GST (8); 0.5 (7) or 2 mM of GST-hSNF5 (9).
hSNF5-DNM2 interaction T Alfonso-Pé rez et al targets them for degradation in the lysosome, attenuating signalling and therefore potentially acting as a tumour suppressor pathway. In fact, in Drosophila, several endocytic proteins, including dynamin homologues, are tumour suppressors. 35, 36 The dual function of hSNF5 in the SWI/SNF complex and in endocytosis might contribute to explain the specific and aggressive type of tumour raised upon hSNF5 inactivation. It is well known that DNM2 depletion or inhibition provokes cytokinesis failure by blocking completion of abscission. [37] [38] [39] Interestingly, it has been reported that MRT cells present chromosome segregation defects and aneuploidization, 40 typical consequences of cytokinesis failure.
The role of hSNF5 in HIV-1 infection is still unclear. hSNF5 interacts with the integrase of the virus, which seems to be related to the integration preferences of the virus. 41 It has been reported that hSNF5 either stimulates or inhibits in vitro integration, besides modulating several steps of HIV-1 replication. 42 Furthermore, hSNF5 is selectively incorporated into HIV-1 virions. Melikyan et al. 43 reported that HIV-1 enters cells via endocytosis and DNM2-dependent fusion with endosomes. Our results make the connection hSNF5-DNM2 and therefore open the possibility to explore new roles of hSNF5 in different steps of the HIV-1 cell cycle.
MATERIALS AND METHODS

Plasmid constructs
pEYFP-C1-BRG1, pEGFP-N1-hBRM, pEGFP-histone H2A and pEGFP-C2-hSNF5 were constructed by inserting full-length cDNAs into the indicated plasmids. pGFP-DNM2K44A was provided by S Schmid. hSNF5 or DNM2 cDNAs were cloned into pAdRSV-S vector, 44 with flag or Ha tags, respectively. To make pTER-hSNF5, annealed gene-specific oligonucleotides encoding small hairpin RNA (forward sequence 5 0 -GATCCCGCT GAACATCCATGTGGGATTCAAGAGATCCCACATGGATGTTCAGCTTTTTGGAAA)-3 0 were ligated into pTER 45 previously digested with BglII and HindIII. pDsRedMonomer-Hyg-C1 (Clontech, Mountain View, CA, USA) or pEGFP-C2 (Clontech) were used to monitor transfection efficiency. Further details about cloning strategies will be provided upon request. 
Cell extracts
Procedure to obtain nuclear and cytoplasmic extracts was adapted from Cereghini et al. 46 Cells (10 7 ) resuspended in 200 ml of nuclear buffer (NB; 0.5 M sucrose, 15 mM Tris-HCl, pH 7.5, 60 mM KCl, 0.25 mM EDTA, pH 8, 0.125 mM of ethylene glycol tetraacetic acid, pH 8, 0.5 mM spermidine, 0.15 mM spermine, 1 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride and protease inhibitors) were supplemented with 100 ml of 1% NP-40 in HNB and centrifuged at 2500 g for 3 min to get cytoplasmic extracts. Pelleted nuclei resuspended in 25 ml of nuclear extraction buffer (NEB; 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, pH 7.9, 25% glycerol, 1.5 mM MgCl 2 , 0.25 mM EDTA, pH 8, 0.5 mM dithiothreitol, 0.14 hSNF5-DNM2 interaction T Alfonso-Pé rez et al M NaCl, 0.5 mM phenylmethylsulfonyl fluoride and protease inhibitors) were supplemented with 25 ml of 0.7 M NaCl in NEB1 and centrifuged at 12500 g for 15 min to get nuclear extracts. Whole-cell extracts were obtained by lysing 10 7 cells in immunoprecipitation buffer (50 mM Tris-HCl, pH 8, 150 mM NaCl, 1 mM EDTA, pH 8, 1% Triton X-100, 1 mM phenylmethylsulfonyl fluoride and protease inhibitors). Protein concentration was determined by Bradford reactive (Bio-Rad, Hercules, CA, USA). Extracts were separated by SDS-PAGE and visualized by western blot using ECL Plus (GE Healthcare).
Immunofluorescence and imager analysis
Immunofluorescences were performed on glass cover slips as previously described. 47 Confocal images were captured by a confocal microscope (TCS SP5; Leica, Wetzlar, Germany). To carry out vesicles quantification in transfected COS-7 cells colocalization analysis was performed using commands Multy Wavelength cell scoring and Linescan of the Meta Morph Offline 7.1.7.0 (Molecular Devices, Sunnyvale, CA, USA) software. Multy Wavelength cell scoring was used to obtain the percentage of spots per cell with one, two or three stains. More than 8.500 tfn-positive vesicles were quantified from eight cells from two independent experiments. Linescan was used to view the intensity values along a given line in a graphical format.
Fluorescence loss in photobleaching
The fluorescence loss in photobleaching experiments were performed at 37 1C and 5% CO 2 using a confocal microscope (TCS SP5; Leica). Constructs based on the enhanced green fluorescent protein vector pEGFP-C2 (Clontech) were transfected in HeLa cells for 15 h. Living cells were measured in Dulbecco's modified Eagle's medium without red phenol as the imaging medium. For each cell, a square region of interest in the cytoplasm of 37.8 mm 2 (zoom factor 3) was bleached at 33 s intervals (488-nm argon laser at 100% power) for 24 times to ensure the complete loss of cell fluorescence, and images were acquired 0.27 ms after each bleach time (488-nm argon laser at 4% power). Quantification of fluorescence intensities in the nucleus was performed as previously described. 13, [48] [49] [50] The equation for determining relative nuclear fluorescence intensity was adapted from Dundr and Misteli. 48 Yeast two-hybrid assay
The yeast two-hybrid screening was performed with the ProQuest TwoHybrid System (Invitrogen, Life Technologies) in the MaV203 strain, using a ProQuest two-hybrid, 8.5 days after coitum mouse embryo cDNA library was cloned in the prey vector pPC86 (Invitrogen) and full-length hSNF5 was cloned in the pDBLeu vector (Invitrogen) as the bait. Positive clones were identified by growth on selective medium lacking histidine and supplemented with 50 mM 3-amino-1,2,4-triazole. Mapping of the interacting domains involved the following fragments: hSNF5: full-length, amino acids M1-W385; Nter, M1-C147; Rpt1-Rpt2-HR3, S148-W385; Nter-Rpt1-Rpt2, M1-T325; Nter-HR3, DV187-L319, DNM2: full-length, M1-D870; MD-PH-GED-PRD, Q301-D870; GTPasa-PH-GED-PRD, DK327-A511; GTPasa-MD-GED-PRD, DS532-V613; GTPasa-MD-PH-PRD, DN634-S742; GTPasa-MD-PH-GED, M1-T760.
Protein production, purification and pull-down assays Production of proteins was performed in Escherichia coli BL21. GST/GSThSNF5 or His-DNM2 fusion proteins were expressed from pGEX-6P3 (GE Healthcare) or pET28 (Novagen) vectors, and were purified with Glutathione-Sepharose 4B matrix (GE Healthcare) or His-Bind Resin (Novagen, Millipore, Billerica, MA, USA), respectively. GDP (0.5 mM) or GTP-gS were pre-incubated with 1.5 mg purified His-DNM2 for 30 min in 50 ml of pull-down buffer (PD; 16 mM Na 2 HPO 4 , 4 mM NaH 2 PO 4 and 100 mM NaCl) when required. For pull-down, proteins were incubated at 4 1C overnight with 1.5 mg matrix-bound GST or GST-hSNF5 in 300 ml PD buffer supplemented with GDP or GTPgS when required. After washes, proteins were eluted by boiling beads in Laemmli buffer, separated by SDS-PAGE and visualized by western blot.
Proximity ligation assay
The proximity between hSNF5 and dynamin II, BAF155 or CAD was evaluated using the Duolink PLA Kit (Olink Bioscience, Uppsala, Sweeden) according to the manufacturer's protocol. In brief, HeLa cells were grown, fixed and permeabilized as described for immunofluorescence. The samples were incubated as indicated with primary antibodies hSNF5 mouse polyclonal antibody, dynamin II GpAb, BAF155 GpAb and CAD RpAb for 1.5 h at room temperature. Primary antibodies were used either alone as negative controls or in combination. Cells were then incubated with PLUS and MUNUS secondary PLA probes (anti-mouse minus, anti-goat plus or anti-rabbit plus). Detection was carried out with the Duolink Detection Kit Orange (Olink Bioscience). Fluorescence spots from at least 130 cells per condition, from maximum intensity projection confocal images, based on 5 z-planes, were counted automatically using command Granularity of the MetaMorph Offline 7.1.7.0 (Molecular Devices) software. The average number of spots per cell was calculated. The known interaction between hSNF5 and BAFF155 was used as a positive control, and the unknown interaction between hSNF5 and CAD was used as a negative control.
Self-assembly and GTPase assays
For dynamin self-assembly, His-DNM2 (2 mM) was incubated in the absence or the presence of two concentrations (0.5 or 2 mM) of GST or GST-hSNF5 in low ionic strength buffer (20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid pH 7.5, 20 mM PIPES pH 7.5, 2 mM MgCl 2 , 20 mM KCl 1 mM ethylene glycol tetraacetic acid, 1 mM dithiothreitol) at 37 1C for 15 min. Mixtures were centrifuged at 21.000 Â g at 4 1C for 30 min to obtain supernatant and pellet fractions. The supernatant and pellet fractions were analysed by SDS-PAGE and followed by Coomassie blue staining. 24 GTPase hydrolysis by DNM2 was measured as a function of time at 37 1C as described, 51 except that the assay was done in GTPase assay buffer with 20 mM KCl (low salt) or 130 mM KCl (high salt).
Co-immunoprecipitations
Co-immunoprecipitations were performed as previously described. 47 When required, extracts were prepared in the presence of 0.5 mM GTPgS or GDP. Immunoprecipitated proteins and input extracts were subjected to SDS-PAGE and analysed by western blot.
Endocytosis assays
Clathrin-dependent endocytosis and fluid-phase endocytosis were assayed using 10 mg/ml tfn Alexa-Fluor-647 conjugated (Sigma-Aldrich) for 5 min and 1 mg/ml tetramethylrhodamine-dxt 3000 MW for 1 h, respectively, in the absence of serum as previously described. 20, 38 EGF was used at 30 ng/ ml when required. After tfn or dxt incubation, cells were rinsed with phosphate-buffered saline followed by glycine 0.1 M, pH 3.5, 150 mM NaCl to reduce background and processed for immunofluorescence. For quantification, 4120 siRNA-silenced cells from 18 different fields from three independent experiments were recorded. In the case of control siRNA, all cells from 18 different fields were recorded. Confocal images were analysed using command Granularity (in the case of tnf uptake) or integrated intensity per unit area (in the case of dxt uptake) of MetaMorph Offline 7.1.7.0 software. Maximum projections of four planes are shown.
RNA extraction and RT-qPCR
Total RNA was prepared by using the RNeasy mini kit (Qiagen, Germantown, MD, USA). cDNA was synthesized from 1 mg of total RNA with the Super-Script First strand synthesis kit (Invitrogen) and random primers. RTqPCR was performed with SYBR qPCR Mix (Applied Biosystems, Carlsbad, CA, USA) and analysed on an ABI Prism 7000 (Applied Biosystems). Values were normalized to the expression of the GAPDH housekeeping gene. Each experiment was performed in triplicate. Primers used were as follows: hGAPDH-F: Grants BFU2011-23442 and CSD2006-00049 from the Spanish Ministerio de Economía y Competitividad, P06-CVI-4844 from Junta de Andalucía and Fundació n Ramó n Areces.
